Yong He

Trials

Studies that name Yong He as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:46 UTC. Open this list on ClinicalTrials.gov

• N/A
  NCT07833085 · CAIX-targeted PET/CT in Solid Tumors

  Zhongnan Hospital · recruiting · Malignant Solid Tumors, Clear Cell Renal Cell Carcinoma, Lung Cancer (NSCLC) · principal investigator
• Ph4
  NCT07612774 · CAPRA-EVO: a Randomized Serial PCCT Trial of Early Evolocumab After ACS

  West China Hospital · recruiting · Coronary, Coronary Artery Disease · study director
• N/A
  NCT07536165 · Extended Time Window Intravenous Tenecteplase Thrombolysis Registry for Acute Ischemic Stroke

  Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · not yet recruiting · Stroke, Acute Ischemic Stroke · principal investigator
• N/A
  NCT07536074 · Extended Time Window Intravenous Thrombolysis Registry for Acute Ischemic Stroke

  Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · not yet recruiting · Stroke, Acute Ischemic Stroke · principal investigator
• N/A
  NCT07385950 · Evaluation of the Diagnostic Efficacy of a αvβ6/FAP-Targeting Heterodimeric Probe in Patients With Malignant Solid Tumors

  Zhongnan Hospital · not yet recruiting · PET / CT, Solid Tumors, Adult · principal investigator
• N/A
  NCT06916442 · Granzyme B-targeted PET Imaging Monitoring Tumor Responses to Immunotherapy

  Zhongnan Hospital · not yet recruiting · PET/CT, Solid Tumors, Adult, Solid Tumors, Advanced Solid Tumors · principal investigator
• N/A
  NCT06791031 · PCSK9 inhibitoRs for Early Passivation of coRonary athEroSclerotic plaqueS in Acute Coronary Syndromes (REPRESS)

  West China Hospital · not yet recruiting · Coronary Artery Disease · principal investigator
• N/A
  NCT06754839 · Clinical Trial of Ventiflow LP Supporting High-risk Percutaneous Coronary Intervention(PCI)

  Suzhou Hearthill Medical Technology Co.,LTD · not yet recruiting · Coronary Artery Disease, Heart Failure, High-risk PCI · study chair
• N/A
  NCT06032572 · Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)

  Shenzhen Raysight Intelligent Medical Technology Co., Ltd. · unknown · Coronary Artery Disease, Cardiovascular Diseases, Coronary Disease · principal investigator
• N/A
  NCT05835570 · Integrin αvβ6-targeted PET in Malignant Tumors

  Zhongnan Hospital · recruiting · Malignant Neoplasm, PET/CT, Non-Small Cell Lung Cancer · principal investigator
• N/A
  NCT05255926 · CXCR4-targeted PET/CT Imaging in Hematological Malignancies

  Zhongnan Hospital · recruiting · CXCR4, PET/CT, Hematological Malignancy · principal investigator
• N/A
  NCT05034146 · 68Ga-FAPI PET/CT in Malignant Tumors

  Zhongnan Hospital · recruiting · Fibroblast Activation Protein Inhibitor, PET/CT, Malignant Neoplasm · principal investigator
• N/A
  NCT04752345 · Optimal Reperfusion Strategy for STEMI Patients With Anticipated PPCI Delay

  West China Hospital · unknown · ST Elevation Myocardial Infarction · principal investigator
• Ph2
  NCT01864681 · Combination of Metformin With Gefitinib to Treat NSCLC

  Daping Hospital and the Research Institute of Surgery of the Third Military Medical University · completed · NSCLC, EGFR Gene Amplification, Advanced Cancer · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 01:46 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 81 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.